---  
layout: startup_page  
title: "Akribion Therapeutics"  
id: "akribiontherapeutics.com"  
permalink: "/akribiontherapeuticsakribiontherapeutics.com02042025/"  
website: "https://www.akribion-therapeutics.com/"  
funding_round: "Seed"  
funding_amount: "€8M"  
investors: "CARMA FUND, RV Invest, MP Beteiligungs GmbH, Hessen Kapital I, Bruker Invest, High-Tech Gründerfonds"  
about: "Akribion Therapeutics is developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion. Their proprietary G-dase® E nucleases allow for the specific depletion of targeted cells, leaving healthy cells unharmed. This technology has potential applications in oncology, autoimmune diseases, fibrosis, and infectious diseases."  
markets: "Biotechnology, Oncology, Autoimmune Diseases, Fibrosis, Infectious Diseases, CRISPR, Therapeutics"  
hq: "Zwingenberg, Hesse, Germany"  
founded_year: "2023"  
linkedin: "https://www.linkedin.com/company/akribion-therapeutics"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: ""  
pitchbook: "https://pitchbook.com/profiles/company/530280-19"  

date_display: "04-Feb-2025"  
date: "2025-02-04"

# SEO Optimization  
meta_title: "Akribion Therapeutics - Seed Funding (€8M)"  
meta_description: "Akribion Therapeutics, Akribion Therapeutics is developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion. Their proprietary G-dase® E nucle..."  
meta_keywords: "Akribion Therapeutics, Biotechnology, Oncology, Autoimmune Diseases, Fibrosis, Infectious Diseases, CRISPR, Therapeutics, Seed funding"  
canonical_url: "https://startup.projectstartups.com/akribiontherapeuticsakribiontherapeutics.com02042025/"  
---